# Rivopharm S.A., Manno, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/rivopharm-sa/7cc8f5f7-352e-451c-bd6f-5abaec132ce0

> Inspection records and compliance data for Rivopharm S.A. in Manno, -. 4 FDA inspections on record, 1 Form 483, last inspected June 23, 2023.

---

## Details

- Name: Rivopharm S.A.
- FEI Number: 3005884589
- Business Operations: FDF MANUFACTURE
- Address Line 1: Centro Insema
- City: Manno
- State: -
- Zip Code: -
- Country Name: Switzerland
- Address: Centro Insema, Manno, - -, Switzerland
- Country: Switzerland

## Related Documents

- FDA Inspection 1264905 - Rivopharm S.A. - 2023-06-23 — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2023
- [483 - Rivopharm S.A. - 2019-01-18](https://www.keypedia.com/records/483/rivopharm-sa/392efa75-cb07-454d-9c3a-31372ef740d2) — source: FDA, date: January 18, 2019
- [FDA Inspection 1078356 - Rivopharm S.A. - 2019-01-18](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/6be8540d-455e-43b7-b5df-0663469a646c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2019
- [FDA Inspection 948852 - Rivopharm S.A. - 2015-10-30](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/1db04c02-d7c7-4b36-957e-643d5aad923d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2015
- FDA Inspection 873626 - Rivopharm S.A. - 2014-04-03 — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2014

## Related Companies

- [Corden Pharma Fribourg SA](https://www.keypedia.com/companies/corden-pharma-fribourg-sa/749b4152-5491-45ed-8d48-4e05eeb96606)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/31ef3982-06b8-43c1-8e7e-585fb2dd02e7)
- [Unichem Laboratories Limited](https://www.keypedia.com/companies/unichem-laboratories-limited/2b8c7905-52a2-4b2e-a97e-0a1d5b2d88ea)
- [Oishi Koseido Co., Ltd.](https://www.keypedia.com/companies/oishi-koseido-co-ltd/07ae7f38-2728-4248-8ef1-ff0abd9a79e7)
- [Xiamen LP Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/xiamen-lp-pharmaceutical-co-ltd/fb23c997-3591-4cab-a4f2-17802b76cb23)
- [Granules India Limited](https://www.keypedia.com/companies/granules-india-limited/e2f27ea6-6e3b-4432-a874-d34393d76014)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Haupt Pharma Muenster GmbH](https://www.keypedia.com/companies/haupt-pharma-muenster-gmbh/09cdc4cc-6cbc-4904-baa2-d4013dae9741)
- [BioDuro, LLC](https://www.keypedia.com/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)

## Related Officers

- [Public Affairs Specialist](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)
